Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture
Image of the Month
- 426 Downloads
Part of the following topical collections:
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Consent from the patient
Written informed consent was obtained from the patient.
© Springer-Verlag GmbH Germany, part of Springer Nature 2019